PEDIATRICS Vol. 94 No. 4 October 1994, pp. 524-526
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asano, Y.
Right arrow Articles by Ito, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asano, Y.
Right arrow Articles by Ito, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Experience and Reason: Twenty-Year Follow-Up of Protective Immunity of the Oka Strain Live Varicella Vaccine

Yoshizo Asano MD1, Sadao Suga MD1, Tetsushi Yoshikawa MD1, Ikuko Kobayashi MD1, Takehiko Yazaki MD1, Motohiro Shibata MD2, Kazuo Tsuzuki MD2, and Shigemitsu Ito MD2

1 The Departments of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan
2 The Departments of Pediatrics, Chukyo Hospital, Nagoya, Aichi, Japan.

Since the first report on the development of a live attenuated varicella vaccine in 1974, the vaccine has been studied extensively, with largely favorable results, in both healthy and leukemic children. It is now licensed in Japan, Korea, and some European countries, and is being considered for licensure in the United States. Although various clinical trials have established the safety, immunogenicity, and the efficacy of the vaccine, concern has been expressed that waning immunity in the vaccine recipients might allow the occurrence of more severe varicella later in life. We show data relevant to this concern on the approximately 20-year follow-up study of the vaccine recipients; this work further extends the experience of a long-term protective efficacy of the vaccine.

Submitted on January 26, 1994
Accepted on March 10, 1994


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 PediatricsHome page
S. M. Wood, S. S. Shah, A. P. Steenhoff, and R. M. Rutstein
Primary Varicella and Herpes Zoster Among HIV-Infected Children From 1989 to 2006
Pediatrics, January 1, 2008; 121(1): e150 - e156.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
S. Hambleton and A. A. Gershon
Preventing Varicella-Zoster Disease
Clin. Microbiol. Rev., January 1, 2005; 18(1): 70 - 80.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
P. A. Campsall, N. H. C. Au, J. S. Prendiville, D. P. Speert, R. Tan, and E. E. Thomas
Detection and Genotyping of Varicella-Zoster Virus by TaqMan Allelic Discrimination Real-Time PCR
J. Clin. Microbiol., April 1, 2004; 42(4): 1409 - 1413.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
B. D. Tugwell, L. E. Lee, H. Gillette, E. M. Lorber, K. Hedberg, and P. R. Cieslak
Chickenpox Outbreak in a Highly Vaccinated School Population
Pediatrics, March 1, 2004; 113(3): 455 - 459.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
J. Breuer
Live attenuated vaccine for the prevention of varicella-zoster virus infection: does it work, is it safe and do we really need it in the UK?
J. Med. Microbiol., January 1, 2003; 52(1): 1 - 3.
[Full Text] [PDF]

Home page
 Br Med BullHome page
M R Wills, A J Carmichael, and J G P Sissons
Vaccines against persistent DNA virus infections
Br. Med. Bull., July 1, 2002; 62(1): 125 - 138.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
M. Brisson, W J. Edmunds, N. J Gay, E. Miller, J C. Bramley, R. Devi, D. Muir, P. Rice, A H Mohsen, M W McKendrick, et al.
Deaths from chickenpox
BMJ, March 9, 2002; 324(7337): 609 - 609.
[Full Text]

Home page
 J. Clin. Pathol.Home page
J Breuer
Vaccination to prevent varicella and shingles
J. Clin. Pathol., October 1, 2001; 54(10): 743 - 747.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
S A Skull and E E L Wang
Current topic: Varicella vaccination{---}a critical review of the evidence
Arch. Dis. Child., August 1, 2001; 85(2): 83 - 90.
[Full Text] [PDF]

Home page
 CMAJHome page
B. J. Law
Chickenpox vaccination, not chickenpox, should be routine for Canadian children
Can. Med. Assoc. J., May 1, 2001; 164(10): 1454 - 1455.
[Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
D. A. Clements, J. I. Zaref, C. L. Bland, E. B. Walter, and P. M. Coplan
Partial Uptake of Varicella Vaccine and the Epidemiological Effect on Varicella Disease in 11 Day-Care Centers in North Carolina
Arch Pediatr Adolesc Med, April 1, 2001; 155(4): 455 - 461.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. Vazquez, P. S. LaRussa, A. A. Gershon, S. P. Steinberg, K. Freudigman, and E. D. Shapiro
The Effectiveness of the Varicella Vaccine in Clinical Practice
N. Engl. J. Med., March 29, 2001; 344(13): 955 - 960.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
V. N. Loparev, K. McCaustland, B. P. Holloway, P. R. Krause, M. Takayama, and D. S. Schmid
Rapid Genotyping of Varicella-Zoster Virus Vaccine and Wild-Type Strains with Fluorophore-Labeled Hybridization Probes
J. Clin. Microbiol., December 1, 2000; 38(12): 4315 - 4319.
[Abstract] [Full Text]

Home page
 J. Clin. Microbiol.Home page
V. N. Loparev, T. Argaw, P. R. Krause, M. Takayama, and D. S. Schmid
Improved Identification and Differentiation of Varicella-Zoster Virus (VZV) Wild-Type Strains and an Attenuated Varicella Vaccine Strain Using a VZV Open Reading Frame 62-Based PCR
J. Clin. Microbiol., September 1, 2000; 38(9): 3156 - 3160.
[Abstract] [Full Text]

Home page
 PediatricsHome page
Committee on Infectious Diseases
Varicella Vaccine Update
Pediatrics, January 1, 2000; 105(1): 136 - 141.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
A. GERSHON
Varicella: to vaccinate or not to vaccinate?
Arch. Dis. Child., December 1, 1998; 79(6): 470 - 471.
[Full Text]

Home page
 Arch. Dis. Child.Home page
Y J Lim, F T Chew, A Y S Tan, and B W Lee
Risk factors for breakthrough varicella in healthy children
Arch. Dis. Child., December 1, 1998; 79(6): 478 - 480.
[Abstract] [Full Text]

Home page
 Arch DermatolHome page
Varicella-Related Deaths Among Children--United States, 1997
Arch Dermatol, July 1, 1998; 134(7): 891 - 892.
[Full Text] [PDF]

Home page
 JAMAHome page
Varicella-Related Deaths Among Children--United States, 1997
JAMA, June 10, 1998; 279(22): 1773 - 1774.
[Full Text] [PDF]

Home page
 JAMAHome page
H. S. Izurieta, P. M. Strebel, and P. A. Blake
Postlicensure Effectiveness of Varicella Vaccine During an Outbreak in a Child Care Center
JAMA, November 12, 1997; 278(18): 1495 - 1499.
[Abstract] [PDF]

Home page
 JAMAHome page
E. D. Shapiro and P. S. LaRussa
Vaccination for Varicella--Just Do It!
JAMA, November 12, 1997; 278(18): 1529 - 1530.
[Abstract] [PDF]

Home page
 Arch Fam MedHome page
L. L. MacFarlane, M. L. Sanders, and P. J. Carek
Concerns Regarding Universal Varicella Immunization: Time Will Tell
Arch Fam Med, November 1, 1997; 6(6): 537 - 541.
[Abstract] [PDF]

Home page
 PediatricsHome page
C. E. Johnson, T. Stancin, D. Fattlar, L. P. Rome, and M. L. Kumar
A Long-term Prospective Study of Varicella Vaccine in Healthy Children
Pediatrics, November 1, 1997; 100(5): 761 - 766.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
Varicella-Related Deaths Among Adults-- United States, 1997
Arch Dermatol, August 1, 1997; 133(8): 1059 - 1060.
[Abstract] [PDF]

Home page
 BMJHome page
E M Jones and D S Reeves
Controlling chickenpox in hospitals
BMJ, January 4, 1997; 314(7073): 4 - 4.
[Full Text]